Skip to main content
TFX
NYSE Life Sciences

Teleflex Sets FY Adjusted EPS Guidance at $6.25-$6.55

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$123.23
Mkt Cap
$5.455B
52W Low
$100.18
52W High
$139.67
Market data snapshot near publication time

summarizeSummary

Teleflex Inc. has provided its full-year adjusted EPS guidance, projecting a range of $6.25 to $6.55. This new guidance offers a critical update for investors and analysts, serving as a key input for financial models and valuation assessments. The announcement follows the recent appointment of Jason Weidman as the company's new President and CEO, indicating a potential new phase for the company's financial outlook. Traders will closely compare this guidance against current consensus estimates to gauge potential stock price movements and will look for further details in upcoming earnings calls or investor presentations.

At the time of this announcement, TFX was trading at $123.23 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $100.18 to $139.67. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed TFX - Latest Insights

TFX
May 07, 2026, 1:33 PM EDT
Filing Type: 10-Q
Importance Score:
8
TFX
May 07, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
7
TFX
May 07, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
TFX
Apr 30, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
TFX
Apr 22, 2026, 8:21 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
TFX
Apr 21, 2026, 6:41 PM EDT
Source: Reuters
Importance Score:
9
TFX
Mar 27, 2026, 2:48 PM EDT
Filing Type: 8-K
Importance Score:
9
TFX
Mar 17, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
7
TFX
Feb 27, 2026, 4:11 PM EST
Filing Type: 10-K
Importance Score:
9
TFX
Feb 26, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8